DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Telotristat etiprateis the generic ingredient in one branded drug marketed by Tersera and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Telotristat etiprate has sixty-eight patent family members in twenty-nine countries.
Two suppliers are listed for this compound.
Recent Clinical Trials for telotristat etiprate
Identify potential brand extensions & 505(b)(2) entrants
|National Cancer Institute (NCI)||Phase 2|
|Barbara Ann Karmanos Cancer Institute||Phase 2|
Pharmacology for telotristat etiprate
|Drug Class||Tryptophan Hydroxylase Inhibitor |
|Mechanism of Action||Tryptophan Hydroxylase Inhibitors |
|Country||Patent Number||Estimated Expiration|
|Portugal||2091940||⤷ Try it Free|
|European Patent Office||2203444||⤷ Try it Free|
|South Korea||101464391||⤷ Try it Free|
|Mexico||2009006195||⤷ Try it Free|
|Japan||2010512416||⤷ Try it Free|
|Australia||2008304439||⤷ Try it Free|
|>Country||>Patent Number||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2091940||122018000025||Germany||⤷ Try it Free||PRODUCT NAME: TELOTRISTAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ ODER SOLVAT DAVON, EINSCHLIESSLICH TELOTRISTATETHYL; REGISTRATION NO/DATE: EU/1/17/1224 20170918|
|2091940||11/2018||Austria||⤷ Try it Free||PRODUCT NAME: TELOTRISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARER ESTER, ODER EIN SALZ DAVON, INSBESONDERE TELOTRISTATETHYL, INSBESONDERE DAS HIPPURATSALZ VON TELOTRISTATETHYL; REGISTRATION NO/DATE: EU/1/17/1224 (MITTEILUNG) 20170920|
|2091940||18C1009||France||⤷ Try it Free||PRODUCT NAME: TELOTRISTAT OU L'UN DE SES ESTERS PHARMACEUTIQUEMENT ACCEPTABLES, OU L'UN DE LEURS SELS, EN PARTICULIER LE TELOTRISTAT D'ETHYLE ET PLUS PARTICULIEREMENT L'HIPPURATE DE TELOTRISTAT D'ETHYLE; REGISTRATION NO/DATE: EU/1/17/1224 20170920|
|2091940||132018000000181||Italy||⤷ Try it Free||PRODUCT NAME: TELOTRISTAT O UN SUO ESTERE FARMACEUTICAMENTE ACCETTABILE, O UN SUO SALE, IN PARTICOLARE TELOTRISTAT ETILE, PIU IN PARTICOLARE SALE IPPURATO DI TELOTRISAT ETILE(XERMELO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1224, 20170920|
|2091940||2018C/009||Belgium||⤷ Try it Free||DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT|
|2091940||300929||Netherlands||⤷ Try it Free||DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.